naphazoline hydrochloride 0.5 MG/ML
- RxCUI
- 1043597
- RxNorm name
- naphazoline hydrochloride 0.5 MG/ML
- Term type
- SCDC
- Status
- Active
- Updated
- 2026-06-14 07:02:55
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 122010
- Active start
- 122010
- Multiple ingredient
- NO
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| 0.5 MG / 1 ML | naphazoline |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| naphazoline | 7247 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | naphazoline hydrochloride 0.5 MG/ML | NAMES |
| RxNorm Name | naphazoline hydrochloride 0.5 MG/ML | NAMES |
| TTY | SCDC | ATTRIBUTES |
| RxCUI | 1043597 | CODES |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S01GA | Sympathomimetics used as decongestants | ATC1-4 | naphazoline | |
| ATC | R01AB | Sympathomimetics, combinations excl. corticosteroids | ATC1-4 | naphazoline | |
| ATC | R01AA | Sympathomimetics, plain | ATC1-4 | naphazoline | |
| MEDRT | D009278 | Naphazoline | CHEM | has_ingredient | naphazoline |
| MEDRT | D009278 | Naphazoline | CHEM | has_ingredient | naphazoline hydrochloride |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naphazoline |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | naphazoline hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | naphazoline hydrochloride |
| MEDRT | D015812 | Glaucoma, Angle-Closure | DISEASE | ci_with | naphazoline |
| MEDRT | D006940 | Hyperemia | DISEASE | may_treat | naphazoline |
| MEDRT | D006940 | Hyperemia | DISEASE | may_treat | naphazoline hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | naphazoline hydrochloride |
| MEDRT | D012220 | Rhinitis | DISEASE | may_treat | naphazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | naphazoline |
| MEDRT | D012852 | Sinusitis | DISEASE | may_treat | naphazoline hydrochloride |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | naphazoline |
| MEDRT | N0000000209 | Adrenergic alpha-Agonists | MOA | has_moa | naphazoline hydrochloride |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | naphazoline |
| MEDRT | N0000008371 | Conjunctival Arterial Vasoconstriction | PE | has_pe | naphazoline hydrochloride |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | naphazoline |
| MEDRT | N0000008896 | Decreased Nasal and Sinus Secretions | PE | has_pe | naphazoline hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | HYBRID |
| ATTRIBUTES | IN_EXPRESSED_FLAG | P |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | STRENGTH | 0.5 MG/ML |
| ATTRIBUTES | TTY | SCDC |
| CODES | RxCUI | 1043597 |
| NAMES | RXNAV_STR | naphazoline hydrochloride 0.5 MG/ML |
| NAMES | RxNorm Name | naphazoline hydrochloride 0.5 MG/ML |